A phase I trial single dose-escalation study assessing tolerability, pharmacokinetics and pharmacodynamics of CMAB007 in healthy Chinese subjects.
Phase of Trial: Phase I
Latest Information Update: 01 Dec 2015
At a glance
- Drugs Omalizumab (Primary)
- Indications Allergic asthma
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 01 Dec 2015 New trial record